Skip to main content

Table 5 Immunological and ART status of HIV-positive patients

From: The 12-month period prevalence and cardiac manifestations of HIV in patients with acute coronary syndrome at a tertiary hospital in Cape Town, South Africa: a retrospective cross-sectional study

Variable, n (%) except where specified HIV+
Viral load (copies/mL) (n = 26)
 Suppressed (< 200) 17 (65.4%)
 Unsuppressed (> 200) 9 (34.6%)
CD4+ count (cells/mm3) (n = 27)
 Median (IQR) 271 (355)
ART status (n = 30)
 Treated with ART at time of event 20 (66.7%)
 ART-naïve 8 (26.7%)
 Defaulted ARTs 2 (6.7%)
ART regimen (n = 20)
 Tenofovir-emtricitibine-efavirenz 14 (70.0%)
 Abacavir-lamivudine-efavirenz 1 (5.0%)
 Zidovudine-lamivudine-lopinavir/ritonavir 4 (20.0%)
 Stavudine-lamivudine-lopinavir/ritonavir 1 (5.0%)
  1. IQR inter-quartile range, ART anti-retroviral therapy